8281.T

Xebio Holdings Co., Ltd. [8281.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

8281.T Stock Summary

Earnings have grown 7.17% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

The Moving Average Convergence Divergence (MACD) for 8281.T recently turned positive (within last 10 days).

8281.T has more than 2 years of cash runway (25 months)

Earnings are expected to fall -100% next year

Top 10 Correlated ETFs

8281.T

Top 10 Correlated Stocks

8281.T

In the News

8281.T Financial details

Company Rating

Neutral

Market Cap

45.14B

Income

3.42B

Revenue

241.08B

Book val./share

2817.06

Cash/share

470.88

Dividend

Dividend %

3.08%

Employees

2.5K

Optionable

Shortable

Yes

Earnings

10 May 2024

P/E

10.09

Forward P/E

PEG

-9.36

P/S

0.18

P/B

0.35

P/C

2.12

P/FCF

Quick Ratio

0.66

Current Ratio

2.04

Debt / Equity

0.08

LT Debt / Equity

0.06

EPS (TTM)

77.42

EPS next Y

EPS next Q

EPS this Y

40.68%

EPS next Y

EPS next 5Y

EPS last 5Y

23.55%

Revenue last 5Y

0.65%

Revenue Q/Q

7.46%

EPS Q/Q

3498.7%

SMA20

3.25%

SMA50

3.46%

SMA100

8.76%

Inst Own

Inst Trans

ROA

ROE

ROC

0.05%

Gross Margin

38%

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

915.0-1291.0

52W High

-22.54%

52W Low

+9.29%

RSI

Rel Volume

0.66

Avg Volume

111.34K

Volume

73.8K

Perf Week

-2.82%

Perf Month

2.56%

Perf Quarter

5.04%

Perf Half Y

4.17%

Beta

0.436

Volatility

16.19%, 18.51%

Prev Close

1.11%

Price

1000

Change

-1.09%

8281.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	5.21K	5.1K	4.58K	5.05K	5.41K
Net income per share	42.4	9.23	9.32	86.77	122.07
Operating cash flow per share	170.39	-29.52	573.82	50.55	158.78
Free cash flow per share	90.6	-147.32	455.27	-62.9	31.17
Cash per share	-34.68	-156.5	580.44	488.29	341.63
Book value per share	2.67K	2.65K	2.63K	2.68K	2.77K
Tangible book value per share	2.53K	2.54K	2.51K	2.56K	2.62K
Share holders equity per share	2.67K	2.65K	2.63K	2.68K	2.77K
Interest debt per share	62.65	107.82	351.86	346.14	287.21
Market cap	55.02B	39.44B	41.38B	41.87B	46.38B
Enterprise value	39.46B	31.68B	12.49B	17.16B	26.12B
P/E ratio	29.2	96.66	100.44	10.91	8.59
Price to sales ratio	0.24	0.18	0.2	0.19	0.19
POCF ratio	7.27	-30.22	1.63	18.73	6.61
PFCF ratio	13.67	-6.05	2.06	-15.05	33.66
P/B Ratio	0.46	0.34	0.36	0.35	0.38
PTB ratio	0.46	0.34	0.36	0.35	0.38
EV to sales	0.17	0.14	0.06	0.08	0.11
Enterprise value over EBITDA	3.5	3.07	1.4	1.4	1.93
EV to operating cash flow	5.21	-24.28	0.49	7.68	3.72
EV to free cash flow	9.8	-4.86	0.62	-6.17	18.96
Earnings yield	0.03	0.01	0.01	0.09	0.12
Free cash flow yield	0.07	-0.17	0.49	-0.07	0.03
Debt to equity	0.02	0.04	0.13	0.13	0.1
Debt to assets	0.02	0.03	0.07	0.07	0.06
Net debt to EBITDA	-1.38	-0.75	-3.24	-2.02	-1.5
Current ratio	2.07	2.15	2.1	1.97	2.02
Interest coverage	480.5	201.81	22.31	41.66	130.11
Income quality	1.74	-0.41	8.2	0.36	0.79
Dividend Yield	0.03	0.04	0.03	0.03	0.03
Payout ratio	0.83	3.79	3.14	0.35	0.25
Sales general and administrative to revenue	0.32	0.33	0.33	0.32	0.31
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.03	0.03	0.03	0.03	0.03
Capex to operating cash flow	-0.47	3.99	-0.21	-2.24	-0.8
Capex to revenue	-0.02	-0.02	-0.03	-0.02	-0.02
Capex to depreciation	-0.78	-1.17	-1.18	-1.18	-1.39
Stock based compensation to revenue	0	0	0	0	0
Graham number	1.59K	741.96	742.72	2.29K	2.76K
ROIC	0.02	0.01	0	0.02	0.04
Return on tangible assets	0.01	0	0	0.02	0.03
Graham Net	-327.67	-422.87	-275.55	-282.07	-337.84
Working capital	61.12B	63.42B	76.84B	72.33B	73.63B
Tangible asset value	112.3B	112.21B	111.02B	113.21B	115.78B
Net current asset value	52.53B	52.73B	55.5B	57.41B	57.07B
Invested capital	0.02	0.04	0.13	0.13	0.1
Average receivables	23.93B	23.05B	22.66B	23.57B	23.95B
Average payables	16.4B	15.67B	19B	22.77B	22.91B
Average inventory	71.53B	71.88B	73.19B	73.48B	78.32B
Days sales outstanding	38.54	35.04	42.72	38.33	37.29
Days payables outstanding	41.83	39.72	68.33	59.98	57.97
Days of inventory on hand	173.75	201.34	209.75	203.42	199.71
Receivables turnover	9.47	10.42	8.54	9.52	9.79
Payables turnover	8.73	9.19	5.34	6.08	6.3
Inventory turnover	2.1	1.81	1.74	1.79	1.83
ROE	0.02	0	0	0.03	0.04
Capex per share	-79.79	-117.8	-118.55	-113.46	-127.62

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	1.41K	1.33K	1.41K	1.31K	1.4K
Net income per share	46.91	4	44.94	0.77	27.71
Operating cash flow per share	51.57	36.91	48.5	53.65	61.16
Free cash flow per share	51.57	36.91	48.5	53.65	61.16
Cash per share	726.9	666.78	343.13	511.96	470.88
Book value per share	2.77K	2.77K	2.79K	2.8K	2.82K
Tangible book value per share	2.62K	2.62K	2.64K	2.63K	2.64K
Share holders equity per share	2.77K	2.77K	2.79K	2.8K	2.82K
Interest debt per share	290.59	285.99	272.83	253.74	238.92
Market cap	40.5B	46.38B	48.06B	44.21B	42.27B
Enterprise value	17.62B	26.12B	27.06B	29.43B	28.69B
P/E ratio	4.88	65.5	6.05	325.08	8.63
Price to sales ratio	0.65	0.79	0.77	0.77	0.68
POCF ratio	17.76	28.42	22.41	18.64	15.63
PFCF ratio	17.76	28.42	22.41	18.64	15.63
P/B Ratio	0.33	0.38	0.39	0.36	0.34
PTB ratio	0.33	0.38	0.39	0.36	0.34
EV to sales	0.28	0.44	0.43	0.51	0.46
Enterprise value over EBITDA	5.69	20.16	8.53	53.7	16.4
EV to operating cash flow	7.73	16.01	12.62	12.41	10.61
EV to free cash flow	7.73	16.01	12.62	12.41	10.61
Earnings yield	0.05	0	0.04	0	0.03
Free cash flow yield	0.06	0.04	0.04	0.05	0.06
Debt to equity	0.1	0.1	0.1	0.09	0.08
Debt to assets	0.06	0.06	0.06	0.05	0.05
Net debt to EBITDA	-7.39	-15.63	-6.62	-26.97	-7.76
Current ratio	1.87	2.02	1.93	2.04	1.89
Interest coverage	569.67	86.8	104.96	13.23	422.75
Income quality	1.1	9.22	1.08	69.76	2.21
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0.24	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.03	0.03	0.03	0.04	0.04
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	1.71K	499.32	1.68K	220.04	1.33K
ROIC	0.02	0	0.01	0	0.01
Return on tangible assets	0.01	0	0.01	0	0.01
Graham Net	-119.21	-12.69	-416.43	-57.85	-181.53
Working capital	73.45B	73.63B	72.08B	70.73B	70.88B
Tangible asset value	115.8B	115.78B	116.5B	116.31B	116.85B
Net current asset value	56.59B	57.07B	56B	55.37B	56.17B
Invested capital	0.1	0.1	0.1	0.09	0.08
Average receivables	25.53B	26.36B	24.2B	22.96B	25.01B
Average payables	23.62B	24.32B	21.88B	19.91B	20.73B
Average inventory	80.57B	82.59B	82.59B	83.71B	85.93B
Days sales outstanding	40.82	37.34	34.63	34.21	40.65
Days payables outstanding	60.94	56.17	47.91	48.44	53.07
Days of inventory on hand	204.21	193.49	199.13	206.1	214.77
Receivables turnover	2.2	2.41	2.6	2.63	2.21
Payables turnover	1.48	1.6	1.88	1.86	1.7
Inventory turnover	0.44	0.47	0.45	0.44	0.42
ROE	0.02	0	0.02	0	0.01
Capex per share	0	0	0	0	0

8281.T Dividend History

8281.T Frequently Asked Questions

What is Xebio Holdings Co., Ltd. stock symbol ?

Xebio Holdings Co., Ltd. is a JP stock and trading under the symbol 8281.T

What is Xebio Holdings Co., Ltd. stock quote today ?

Xebio Holdings Co., Ltd. stock price is $1000 today.

Is Xebio Holdings Co., Ltd. stock public?

Yes, Xebio Holdings Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 111.34K
Market Capitalization 45.14B
Employee 2.5K
CEO Mr. Tomoyoshi Morohashi
Headquarters Koriyama,JP
IPO Date 2001-01-01
Website https://www.xebio.co.jp

Xebio Holdings Co., Ltd., together with its subsidiaries, engages in sporting goods business in Japan. The company is involved in sporting goods retail activities, as well as the sale of sporting goods and apparels. It operates integrated mega specialty stores under The Super Sports XEBIO brand; small and medium scale sporting equipment specialty stores under the XEBIO Sports Express brand; urban sporting goods specialty stores under the Victoria brand; small-scale sporting goods stores under the NEXAS brand; sporting goods specialty stores under the Takeda Sports brand; golf products specialty stores under the Victoria Golf and Golf Partner brands; outdoor specialty stores under the L-Breath brand; and specialty apparel stores under the next and X'tyle brands. The company also operates sports eyewear stores under the X'tyleVision brand; health food and fitness, and medical products stores under the Xiasis brand; Free Blades, an ice hockey club team; Xebio Arena, a sports arena; and sports community station stores under the XSPOT brand. In addition, it engages in purchase and sale of golf goods; marketing project, research and consulting, event promotion, and property management activities; and international business, and research and development operations. Further, the company is involved in providing sports related digital platforms; and e-commerce management business. Additionally, it engages in sales agency business, human resource development, and temporary staffing service; and credit card business. The company was founded in 1962 and is headquartered in Koriyama, Japan.